Welcome to our dedicated page for Hyster-Yale SEC filings (Ticker: HY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hyster-Yale, Inc. (NYSE: HY) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As a Delaware-incorporated public company, Hyster-Yale submits current reports on Form 8-K that describe material events such as financial results, restructuring plans, executive officer changes and credit agreements.
Recent 8-K filings include disclosures about quarterly results, where the company reports consolidated revenues, operating profit or loss, segment performance for its lift truck business in the Americas, EMEA and JAPIC, and results for Bolzoni and Nuvera-related activities. Other 8-Ks describe a restructuring plan that reduces the global workforce by approximately 575 employees, the strategic realignment of Nuvera into an integrated energy solutions program, and changes in senior financial leadership.
Hyster-Yale has also filed an 8-K detailing a Third Amended and Restated Loan, Security and Guaranty Agreement that establishes a revolving credit facility with domestic and foreign components, secured by liens on working capital and other assets and subject to covenants on borrowings, dividends and financial ratios. These filings help investors understand the company’s liquidity, leverage and capital structure.
On Stock Titan, AI-powered summaries can help explain the key points in lengthy filings, highlighting items such as restructuring charges, dividend-related disclosures, new credit facilities and management changes. Users can monitor real-time updates from EDGAR, review quarterly earnings-related 8-Ks alongside annual and quarterly reports when available, and examine executive and board changes reported under Item 5.02. This page is a resource for analyzing how Hyster-Yale’s regulatory filings reflect its operating performance, risk factors and strategic decisions in the global materials handling market.
Hyster-Yale, Inc. director John P. Jumper indirectly acquired 1,139 shares of Class A Common Stock on a grant basis. The shares were awarded at $0.00 per share as “Required Shares” under the company’s Non-Employee Directors’ Equity Compensation Plan and are held in a trust for his benefit. Following this award, he indirectly holds 29,112 shares of Class A Common Stock.
RANKIN CHLOE O reported acquisition or exercise transactions in this Form 4 filing.
Hyster-Yale, Inc. insider filing shows an indirect share award linked to Chloe O. Rankin. An award of 1,139 shares of Class A Common Stock was granted at no cost as “Required Shares” to her spouse under the company’s Non-Employee Directors' Equity Compensation Plan, bringing related indirect Class A holdings to 245,520 shares. The filing also lists multiple indirect Class B Common Stock positions held through family trusts and partnerships that are convertible into Class A Common Stock. The reporting person disclaims beneficial ownership of all such shares.
Hyster-Yale, Inc. reporting person Helen Rankin Butler reported an indirect acquisition related to her spouse. Entities associated with Butler received 1,139 shares of Class A Common Stock at $0.00 per share as “Required Shares” under the company’s Non-Employee Directors’ Equity Compensation Plan, held in the J.C. Butler, Jr. Revocable Trust. Butler disclaims beneficial ownership of these shares.
The filing also lists a range of indirect holdings and derivative positions in Class B Common Stock (convertible into Class A) and Class A Common Stock across multiple family trusts, limited partnerships, and retirement accounts. These entries update reported indirect positions and do not show any open-market purchases or sales.
Hyster-Yale, Inc. reporting person Clara R. Williams reported one compensation-related acquisition and multiple indirect holdings. An award of 1,139 shares of Class A Common Stock was granted at $0.00 per share as “Required Shares” to her spouse under the company’s Non-Employee Directors’ Equity Compensation Plan, held in a trust where the spouse serves as trustee. Following this, that indirect Class A position shows 24,649 shares. Numerous additional lines simply update indirect interests in Class A and Class B shares held through various family trusts and partnerships, with no open-market buys or sells reported. A footnote states that Williams disclaims beneficial ownership of all such shares.
WILLIAMS DAVID B reported acquisition or exercise transactions in this Form 4 filing.
Hyster-Yale, Inc. director David B. Williams reported an equity award of 1,139 shares of Class A Common Stock. The shares were granted at no cost as “Required Shares” under the company’s Non-Employee Directors' Equity Compensation Plan and are held in a trust for his benefit.
Following this grant, that trust holds 24,649 Class A shares indirectly for him. The filing also lists numerous additional indirect holdings of Class A and Class B shares through family trusts and partnership interests, and Williams disclaims beneficial ownership of all such shares.
BUTLER JOHN C JR reported acquisition or exercise transactions in this Form 4 filing.
Hyster-Yale, Inc. director John C. Butler Jr. reported an award of 1,139 shares of Class A Common Stock on 2026-04-02. The shares were granted at $0.00 as “Required Shares” under the company’s Non-Employee Directors' Equity Compensation Plan and are held in a trust for his benefit.
Following this grant, that trust holds 59,260 Class A shares indirectly. The filing also lists various indirect Class A and Class B holdings through family trusts, partnerships, and an individual retirement account, but shows no open‑market purchases or sales. Butler disclaims beneficial ownership of the reported indirect holdings.
RANKIN CLAIBORNE R reported acquisition or exercise transactions in this Form 4 filing.
Hyster-Yale, Inc. director Claiborne R. Rankin reported an equity award of Class A shares held through a trust. On April 2, 2026, a trust for his benefit received 1,139 shares of Class A Common Stock as “Required Shares” under the company’s Non-Employee Directors’ Equity Compensation Plan at a stated price of $0.00 per share. After this award, that trust holds 245,520 Class A shares, with Mr. Rankin serving as trustee and disclaiming beneficial ownership of those shares. The filing also lists numerous indirect holdings of Class B Common Stock, each tied to underlying Class A shares through family partnerships and trusts, with no open-market purchases or sales disclosed.
O'Hara Ann reported acquisition or exercise transactions in this Form 4 filing.
Hyster-Yale director Ann O'Hara reported receiving an equity award of 1,139 shares of Class A Common Stock. The shares were granted at $0.00 per share as “Required Shares” under the company’s Non-Employee Directors' Equity Compensation Plan, reflecting routine board compensation rather than a market purchase. Following this grant, O'Hara directly holds 5,271 Class A shares.
Hyster-Yale, Inc. director Dennis W. LaBarre received 1,139 shares of Class A Common Stock as an equity award. The shares were granted at a price of $0.00 per share as “Required Shares” under the company’s Non-Employee Directors' Equity Compensation Plan. Following the grant, he directly holds 37,884 Class A shares. He also directly holds 9,424 shares of Class B Common Stock, which are linked to 9,424 underlying Class A shares at a $0.00 exercise price.
Eliopoulos Edward T reported acquisition or exercise transactions in this Form 4 filing.
Hyster-Yale, Inc. director Edward T. Eliopoulos received an award of 1,139 shares of Class A Common Stock. The shares were granted at no stated price as “Required Shares” under the company’s Non-Employee Directors' Equity Compensation Plan and are held in a trust for his benefit.
After this grant, indirect holdings attributed to him total 16,722 Class A shares, reflecting routine equity-based compensation for a non-employee director rather than an open-market purchase.